FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093025 [Registered on: 13/08/2025] Trial Registered Prospectively
Last Modified On: 06/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device
Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Supporting Arm and Hand Recovery After Stroke with Non-Invasive Therapy 
Scientific Title of Study   Effects of Repetitive-Transcranial Magnetic Stimulation on Neurophysiological and Clinical Outcomes in Upper Limb Post-stroke recovery 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kaviraja Udupa 
Designation  Professor 
Affiliation  National Institute of Mental Health and Neurosciences(NIMHANS)) 
Address  Department of Neurophysiology, NIMHANS, Bengaluru 560029, Karanataka

Bangalore
KARNATAKA
560029
India 
Phone  08026995914  
Fax    
Email  kaviudupa@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kaviraja Udupa 
Designation  Professor 
Affiliation  National Institute of Mental Health and Neurosciences(NIMHANS)) 
Address  Department of Neurophysiology, NIMHANS, Bengaluru 560029, Karanataka

Bangalore
KARNATAKA
560029
India 
Phone  08026995914  
Fax    
Email  kaviudupa@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Kaviraja Udupa 
Designation  Professor 
Affiliation  National Institute of Mental Health and Neurosciences(NIMHANS)) 
Address  Department of Neurophysiology, NIMHANS, Bengaluru 560029, Karanataka

Bangalore
KARNATAKA
560029
India 
Phone  08026995914  
Fax    
Email  kaviudupa@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Mental Health and Neuro Sciences, Government of India, Hosur Road, Bengaluru-560029, Karnataka, INDIA 
 
Primary Sponsor  
Name  NIMHANS 
Address  NIMHANS, Bengaluru 560029, Karnataka 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kaviraja Udupa  National Institute of Mental Health and Neuro Sciences  Room no : 1010, Special OPD Block, CNN Laboratory, Department of Neurophysiology, NIMHANS, Bengaluru India, 560029 Banglore, Karanataka
Bangalore
KARNATAKA 
08026995914

kaviudupa@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Institute Ethics Committee  Not Applicable 
Institute Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G938||Other specified disorders of brain,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Repetitive Transcranial Magnetic stimulation (rTMS)   Stroke patients with 7 days of Repetitive Transcranial Magnetic stimulation (rTMS) intervention. The treatment protocol involves administering low-frequency repetitive transcranial magnetic stimulation (rTMS) as an inhibitory stimulus to attenuate hyperexcitability by inducing long-term depression (LTD)-like effects in cortical neurons. The butterfly-shaped TMS coil is positioned over the primary motor cortex (M1) region, corresponding to the C3 or C4(depending on the stroke hemisphere) location in the international 10-20 EEG system, on the hemisphere contralateral to the lesioned side. The low-frequency stimulation (1 Hz) of 1200 pulses with insterstimulus interval of 1 second is applied to the contralesional M1 (unaffected hemisphere) for 20 min in stroke patients, The intervention is delivered over seven consecutive days, comprising 12 sessions in total, one session on days 1 and 7, and two sessions per day from days 2 to 6.  
Comparator Agent  Standard of Care  Stroke patients in this group will receive pharmacotherapy and physiotherapy during the subacute phase, without any repetitive transcranial magnetic stimulation (rTMS) intervention. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient with ischemic stroke (based on TOAST criteria)
1. with upper limb motor impairment– hemiplegia/monoplegia (based on MRC scale)
2. in early sub-acute phase of stroke
3. age range 18-60 years old
4. anterior circulation stroke
5. with moderate and severe disability modified Rankin Scale (mRS) score ranges from 2 to 5
6. with moderate and severe stroke severity National Institutes of Health Stroke Scale (NIHSS) 5 to 42
 
 
ExclusionCriteria 
Details  1. Patients who
i. are unable to cooperate due to global aphasia
ii. are having cerebral venous thrombosis
iii. are in ICU ventilators, cardio-respiratory distress
iv. are having hemorrhagic stroke
v. are having Primary Psychiatric disorders

2. Patients have contraindications to TMS, such as those who
i. had a past history or family history of seizures and epilepsy
ii. have epileptic discharge in EEG
iii. Had a H/O LOC due to seizures and brain tumors
iv. have metal implants on the head and neck such as surgical clips, dental implants, cochlear implants, stents in the head and neck
v. have undergone decompressive craniotomy
vi. having a cardiac pacemaker or cardiac stent
vii. are pregnant
viii. had a H/O cardiovascular disease such as Ischemic Heart Disease with low ejection fraction and cardiac failure
ix. have a history of brain tumor
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate the effect of rTMS in post-stroke patients in terms of Clinical outcome measures using BI- Barthel Index, MRS-Modified Rankin Scale, NIHSS- National Institute of Health Stroke Scale, WMFT- Wolf Motor Function Test
 
Baseline- Preintervention Day -1
Postintervention Day-7 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the effect of rTMS in post-stroke patients in terms of Neurophysiological measures using Single-pulse and paired-pulse TMS measures, Heart Rate Variability Measures (HRV) and Electroencephalographic measures (EEG)
 
Baseline- Preintervention Day -1
Postintervention Day-7 
 
Target Sample Size   Total Sample Size="66"
Sample Size from India="66" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   08/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

In stroke majority of patients experience upper limb motor impairments, with a mere 5-20% regaining the full functionality. Upper limb dysfunction ultimately impairs a stroke patient’s quality of life and independence . This limitation can profoundly impact their daily lives, hindering activities like food, clothing, and personal cleanliness and ultimately compromising their independence. The balance between the brain hemispheres were disrupted by stroke leading to motor impairment .  Researchers have investigated the use of rTMS to restore the upper limb function and also to improve the quality of life in the stroke survivors. This non-invasive technique involves stimulating either the unaffected or affected hemisphere with low-frequency or high-frequency pulses, respectively. The goal is to rebalance brain activity and promote functional recovery post-stroke .

While previous research has extensively explored the effects of rTMS on post-stroke upper limb motor recovery, the underlying neurophysiological mechanisms remain less understood. Specifically, the role of intracortical circuits, particularly GABAergic interneurons, in mediating these effects is not well-established. Additionally, the impact of rTMS on heart rate variability, and its association with frontal vagal network activity is under-investigated. Furthermore, there is a paucity of research on the effectiveness of rTMS in Indian stroke patients and the associated neurophysiological changes, considering the potential influence of ethnicity on treatment outcomes. Thus, the present study aims to investigate the impact of rTMS using neurophysiological and clinical outcomes in post-stroke upper limb recovery.

 
Close